Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Pennsylvania › Reading
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Reading, PA keessatti
Qorannoo 9 Kansara Qara'a Non-Small Cell f Reading fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Namoota walitti qabaa jiraSadarkaa 3
- Reading Hospital, West Reading · Miili 1 fagaatti
- Ephrata Cancer Center, Ephrata · Miili 17 fagaatti
- Sechler Family Cancer Center, Lebanon · Miili 26 fagaatti
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Namoota walitti qabaa jiraSadarkaa 3
- Reading Hospital, West Reading · Miili 1 fagaatti
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- McGlinn Cancer Institute Reading Hospital, West Reading · Miili 1 fagaatti
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Reading Hospital - McGlinn Cancer Institute, West Reading · Miili 1 fagaatti
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Ephrata Cancer Center, Ephrata · Miili 17 fagaatti
- Sechler Family Cancer Center, Lebanon · Miili 26 fagaatti
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Ephrata Cancer Center, Ephrata · Miili 17 fagaatti
- Sechler Family Cancer Center, Lebanon · Miili 26 fagaatti
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Ephrata Cancer Center, Ephrata · Miili 17 fagaatti
- Sechler Family Cancer Center, Lebanon · Miili 26 fagaatti
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2/3
- Ephrata Cancer Center, Ephrata · Miili 17 fagaatti
- Sechler Family Cancer Center, Lebanon · Miili 26 fagaatti
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ephrata Cancer Center, Ephrata · Miili 17 fagaatti
- Sechler Family Cancer Center, Lebanon · Miili 26 fagaatti
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 120
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 56
- Washington, DCQorannoo 55
Qorannoo biroo Reading keessatti
- Dhibee QaraQorannoo 11
- Leukemia Myeloidii HamaaQorannoo 5
- Saree OljooQorannoo 5
- Dhibee Rakkoo Hir'ina OofuuQorannoo 5
- Kansarii ProstateQorannoo 4
- Saree (Gosoota Hunda)Qorannoo 4
- Kansarii ColorectalQorannoo 3
- NarcolepsyQorannoo 3
- Rakkina RakkooQorannoo 3
- GaddaQorannoo 3
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.